Portage Biotech Inc (NAS:PRTG)
$ 6 3.1097 (115.16%) Market Cap: 6.29 Mil Enterprise Value: 1.31 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 35/100

Portage Biotech Inc at Citi Virtual Oncology Leadership Summit Transcript

Feb 22, 2023 / 02:00PM GMT
Release Date Price: $77 (+0.44%)
James Nicholson
Citigroup Inc. - Analyst

Good morning, everyone. My name is James Nicholson, and I sit in the healthcare investment banking group here at Citi, covering life sciences. I'm proud to be hosting this morning the fireside chat with Portage Biotech at Citi's Oncology Leadership Summit.

Portage is a biotech company developing first-in-class and best-in-class small molecules in the I/O space. I'm very happy to be joined this morning by Ian Walters, the CEO and Chairman of Portage; as well as Allan Shaw, the CFO.

Ian and Allan, thanks again for making the time to speak with us today, it's much appreciated.

Questions & Answers

James Nicholson
Citigroup Inc. - Analyst

And I'd like to maybe kick it off, if you don't mind, giving us a little bit background on your professional history, both in academia and in industry.

Ian Walters
Portage Biotech Inc. - CEO, Chairman, & Director

Great, thanks. Good morning, James, and thanks for having us at this conference. So my background,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot